Recent Patents on CNS Drug Discovery

Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
pp. 1-27(27)
Authors: Chaki, Shigeyuki; Okubo, Taketoshi; Sekiguchi, Yoshinori

Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression
pp. 29-41(13)
Authors: Brink, Christiaan B.; Harvey, Brian H.; Brand, Linda

Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia
pp. 43-53(11)
Author: Hashimoto, Kenji

The Quest to Repair the Damaged Spinal Cord
pp. 55-63(9)
Authors: Moreno-Flores, Maria T.; Avila, Jesus

TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
pp. 65-76(12)
Authors: Roberts, Louise A.; Connor, Mark

Miglustat: Substrate Reduction Therapy for Lysosomal Storage Disorders Associated with Primary Central Nervous System Involvement
pp. 77-82(6)
Author: Pastores, Gregory M.

Voltage-Gated Sodium Channel Blockers as Immunomodulators
pp. 83-91(9)
Authors: Roselli, Francesco; Livrea, Paolo; Jirillo, Emilio

The Astrocytic GABAA/Benzodiazepine-Like Receptor: The Joker Receptor for Benzodiazepine-Mimetic Drugs?
pp. 93-103(11)
Authors: Hertz, Leif; Zhao, Zhong; Chen, Ye

Galanthamine, a Natural Product for the Treatment of Alzheimer's Disease
pp. 105-111(7)
Authors: Marco, Luis; Carreiras, Maria d.C.

An Update on GABA Analogs for CNS Drug Discovery
pp. 113-118(6)
Authors: Yogeeswari, Perumal; Ragavendran, Jegadeesan V.; Sriram, Dharmarajan

Therapeutic Perspectives in Alzheimer's Disease
pp. 119-127(9)
Authors: Tschape, Jakob-A.; Hartmann, Tobias

Patent Annotations
pp. 129-132(4)

Patent Selections
pp. 133-138(6)